SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001816079-20-000015
Filing Date
2020-08-17
Accepted
2020-08-17 10:11:21
Documents
2
Effectiveness Date
2020-08-17

Document Format Files

Seq Description Document Type Size
1 2020 SECOND LETTER TO SHAREHOLDERS AUTHORED BY JERALD HAMMANN letterHammann20200817filing.htm DFAN14A 42692
2 2020 SECOND LETTER TO SHAREHOLDERS AUTHORED BY JERALD HAMMANN (PDF) letterHammann20200817filing.pdf DFAN14A 175359
  Complete submission text file 0001816079-20-000015.txt   285800
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Subject) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-15327 | Film No.: 201108273
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1566 SUMTER AVE N MINNEAPOLIS MN 55427-4048
Business Address
Hammann Jerald (Filed by) CIK: 0001816079 (see all company filings)

Type: DFAN14A